“REAl LIfe” observational study on the effectiveness of Evusheld prophylaxis against SARS-CoV-2 omicron variants in vaccine non-responder immunocompromised patients (REALISE)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

“REAl LIfe” observational study on the effectiveness of Evusheld prophylaxis against SARS-CoV-2 omicron variants in vaccine non-responder immunocompromised patients (REALISE)

Published:2024-10 Issue:23 Volume:42 Page:126208
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Esposito Giuliana Lucia,Fassio Federico,Girardi Daniela,Picasso Erica,Meloni Federica,Montini Simone,Codullo Veronica,Pattonieri Eleonora Francesca,Defrancesco Irene,Bianchessi Antonio,Calvi Monica,Seminari Elena Maria,Baldanti Fausto,Lilleri Daniele,Novelli Viola,Marena Carlo

Funder

Fondazione IRCCS Policlinico San Matteo

Publisher

Elsevier BV

Reference24 articles.

1. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients;Boyarsky;JAMA,2021

2. Immunogenicity of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients;Holden;J Intern Med,2021

3. Impaired humoral response in renal transplant recipients to SARS-CoV-2 vaccination with BNT162b2 (Pfizer-BioNTech);Korth;Viruses,2021

4. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis;Lee;BMJ,2022

5. Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: a Case series;Werbel;Ann Intern Med,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP